Active — Not RecruitingPhase 2

Induction Modified TPF Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Spain40 participantsStarted 2019-05-01

Plain-language summary

The purpose of the study is to evaluate the efficacy and safety of induction mTPF chemotherapy followed by concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck cancer

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. CT scan or MRI of the neck and CT scan of the chest or
✓. FDG18 PET TC

What they're measuring

objective response rate (ORR)

Timeframe: 12 weeks after radiotherapy termination

Trial details

NCT IDNCT05527782

SponsorHospital Universitario Doctor Peset

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08

View on ClinicalTrials.gov More Locally Advanced Head and Neck Squamous Cell Carcinoma trials